Allergy Therapeutics (AGY) Stock Chart & Stock Price History GBX 5.30 -0.22 (-3.99%) (As of 11:47 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Allergy Therapeutics Stock Price Performance 5 Day Performance-2.21%1 Month Performance+8.61%3 Month Performance+11.23%6 Month Performance+63.08%Year-To-Date Performance+112.00%1 Year Performance+207.25% Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address A huge crack is forming in the US economy (Ad)Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. AGY Stock Chart for Monday, November, 18, 2024 AGY Chart by TradingView Allergy Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024GBX 5.50GBX 5.52+0.36%GBX 5.52GBX 5359,407 shs£263.30 million11/14/2024GBX 5.42GBX 5.50+1.48%GBX 5.50GBX 5.17121,290 shs£262.35 million11/13/2024GBX 5.60GBX 5.42-3.21%GBX 5.50GBX 4.50493,909 shs£258.53 million11/12/2024GBX 5.54GBX 5.60+1.08%GBX 5.60GBX 4.50694,589 shs£267.12 million11/11/2024GBX 5.40GBX 5.54+2.59%GBX 5.54GBX 4.97176,798 shs£264.26 million11/08/2024GBX 5.60GBX 5.40-3.57%GBX 5.60GBX 4.89913,436 shs£257.58 million Get the Latest News and Ratings for AGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024GBX 5.50GBX 5.60+1.82%GBX 5.60GBX 4.50249,343 shs£267.12 million11/06/2024GBX 5.42GBX 5.50+1.48%GBX 5.50GBX 4.89354,004 shs£262.35 million11/05/2024GBX 5.50GBX 5.42-1.45%GBX 5.50GBX 4.50303,852 shs£258.53 million11/04/2024GBX 5.50GBX 5.50GBX 5.50GBX 4.87130,947 shs£262.35 million11/01/2024GBX 4.82GBX 4.83+0.31%GBX 5.40GBX 4.83378,717 shs£230.39 million10/31/2024GBX 5.28GBX 4.82-8.81%GBX 5.40GBX 4.81378,999 shs£229.68 million10/30/2024GBX 4.82GBX 5.28+9.66%GBX 5.28GBX 4.50517,234 shs£251.86 million10/29/2024GBX 5.20GBX 4.82-7.31%GBX 5.24GBX 4.821.04 million shs£229.68 million10/28/2024GBX 5.30GBX 5.20-1.98%GBX 5.50GBX 4.701.56 million shs£247.80 million10/25/2024GBX 4.76GBX 5.30+11.46%GBX 5.30GBX 5310,186 shs£252.81 million10/24/2024GBX 5GBX 4.76-4.90%GBX 5.50GBX 4.501.14 million shs£226.81 million10/23/2024GBX 4.88GBX 5+2.46%GBX 5GBX 4.63447,101 shs£238.50 million10/22/2024GBX 5GBX 4.88-2.40%GBX 5GBX 4.76244,684 shs£232.78 million10/21/2024GBX 4.88GBX 5+2.46%GBX 5GBX 4.66393,950 shs£238.50 million10/18/2024GBX 4.75GBX 4.88+2.74%GBX 5GBX 4.52719,509 shs£232.78 million10/17/2024GBX 5GBX 4.75-5.00%GBX 5GBX 4.50380,148 shs£226.58 million Related Companies INDV Stock Chart APH Stock Chart ANCR Stock Chart BXP Stock Chart EAH Stock Chart STX Stock Chart CEL Stock Chart PXS Stock Chart CHLL Stock Chart RGT Stock Chart Receive AGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AGY) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on...Wide Moat Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
